NCPA questions CMS calculations for FULs
The Centers for Medicare & Medicaid Services (CMS) is relying on flawed average manufacturer price (AMP) data to calculate new caps on Medicaid pharmacy reimbursement — known as federal upper limits (FULs) — for multiple-source generic prescription drugs, according to the National Community Pharmac